Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

US Patent 8748114 · Granted Jun 10, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Evaluation of mantle cell lymphoma and methods related thereto2023
Evaluation of mantle cell lymphoma and methods related thereto2023
Method for determining lymphoma type and providing treatment2023
Method for determining lymphoma type and providing treatment2023
Method for subtyping lymphoma types by means of expression profiling2023
Method for subtyping lymphoma types by means of expression profiling2023
Antibody targeting cell surface deposited complement protein C3d and use thereof2022
Survival predictor for diffuse large B cell lymphoma2021
Survival predictor for diffuse large B cell lymphoma2021
Survival predictor for diffuse large B cell lymphoma2021
Methods for identifying, diagnosing, and predicting survival of lymphomas2020
Methods for identifying, diagnosing, and predicting survival of lymphomas2020